Lidocaine Hydrochloride

Hospira, Inc.🇺🇸 United States

FDA Page

Effective Date: May 22, 2026
Approval ID: 89a4bd73-89f4-4fd7-2c9f-921e1da8f96b
Products: 1 registered
Version: 24

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

4% Lidocaine Hydrochloride Injection, USP (40 mg/mL) AQUEOUS SOLUTION FOR TOPICAL USE AND RETROBULBAR INJECTION

Quick Stats

Total Products1

Labelers2

Label Sections13

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.